ProAssurance (PRA) Scheduled to Post Earnings on Monday

ProAssurance (NYSE:PRA) is set to post its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect ProAssurance to post earnings of $0.04 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

ProAssurance (NYSE:PRA) last announced its earnings results on Tuesday, February 27th. The insurance provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.09). The company had revenue of $296.96 million during the quarter, compared to analysts’ expectations of $252.74 million. ProAssurance had a negative return on equity of 0.53% and a negative net margin of 3.39%. ProAssurance’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.06 EPS. On average, analysts expect ProAssurance to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

ProAssurance Price Performance

Shares of ProAssurance stock opened at $13.17 on Monday. The stock has a market cap of $671.27 million, a price-to-earnings ratio of -17.80 and a beta of 0.24. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.27 and a current ratio of 0.27. The stock has a 50 day moving average price of $12.80 and a 200-day moving average price of $13.72. ProAssurance has a one year low of $11.76 and a one year high of $19.38.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on PRA. JMP Securities reiterated a “market outperform” rating and issued a $22.00 target price on shares of ProAssurance in a report on Monday, April 15th. Piper Sandler decreased their price target on ProAssurance from $16.00 to $15.00 and set an “overweight” rating for the company in a research note on Monday, March 4th. Finally, Truist Financial decreased their price target on ProAssurance from $15.00 to $14.00 and set a “hold” rating for the company in a research note on Thursday, February 29th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, ProAssurance has a consensus rating of “Moderate Buy” and an average price target of $17.00.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.